ARTICLE | Company News
FDA approves Valera's Vantas
October 13, 2004 7:00 AM UTC
The FDA granted marketing approval to Valera (Cranbury, N.J.) for Vantas, a long-acting luteinizing hormone-releasing hormone ( LHRH) hydrogel implant for the palliative treatment of advanced prostate...